Found 605 matching trials
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial PHASE2 The investigators preliminary data suggests that FOLFOX-A may have equal or...
Show More Learn More & Join Trial
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) PHASE1 GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) PHASE2 This clinical study is in subjects who are 18 years old or older with local...
Show More Location
Mayo Clinic - Arizona
Learn More & Join Trial
Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC PHASE2 We want to compare Taxol given weekly with Taxotere given every 3 week both...
Show More Location
Ullevål university hospital
Learn More & Join Trial
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer PHASE2 This is a single-arm, phase II study aiming to evaluate the feasibility and...
Show More Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA NA The aim of this study was to compare the efficacy and safety of mFOLFOX, mF...
Show More Learn More & Join Trial
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line PHASE3 This study is designed to evaluate the efficacy and safety of first-line tr...
Show More Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Learn More & Join Trial